The need is growing rapidly for effective therapies to treat infectious diseases, and developing those therapies is more complex than ever before. At PPD, we understand the challenges and help our clients navigate and minimize the complexities. Our strategy begins with well-written concepts and protocols that serve as the roadmap to developing the optimal plans for anti-infective, antifungal, antiviral and vaccine studies.
With our global network of therapeutic and regulatory experts, we help clients understand standards of care and regulations every step of the way to ensure that timelines are met.
In the past five years, our infectious diseases team:
- Conducted more than 550 trials in all major markets
- Enrolled more than 340,000 patients at more than 12,000 sites